Australian Group on Antimicrobial Resistance Community-onset Gram-negative Surveillance Program annual report, 2010
dc.contributor.author | Turnidge, J. | |
dc.contributor.author | Gottlieb, T. | |
dc.contributor.author | Mitchell, D. | |
dc.contributor.author | Coombs, Geoffrey | |
dc.contributor.author | Pearson, J. | |
dc.contributor.author | Bell, J. | |
dc.date.accessioned | 2017-01-30T12:05:45Z | |
dc.date.available | 2017-01-30T12:05:45Z | |
dc.date.created | 2015-10-29T04:09:56Z | |
dc.date.issued | 2013 | |
dc.identifier.citation | Turnidge, J. and Gottlieb, T. and Mitchell, D. and Coombs, G. and Pearson, J. and Bell, J. 2013. Australian Group on Antimicrobial Resistance Community-onset Gram-negative Surveillance Program annual report, 2010. Communicable Diseases Intelligence Quarterly Report. 37 (3): pp. E219-E223. | |
dc.identifier.uri | http://hdl.handle.net/20.500.11937/18055 | |
dc.description.abstract |
The Australian Group on Antimicrobial Resistance (AGAR) performs regular period-prevalence studies to monitor changes in antimicrobial resistance in selected enteric Gram-negative pathogens. The 2010 survey focussed on community-onset infections, examining isolates from urinary tract infections from patients presenting to outpatient clinics, emergency departments or to community practitioners. Two thousand and ninety-two Escherichia coli, 578 Klebsiella species and 268 Enterobacter species were tested using a commercial automated method (Vitek 2, BioMérieux) and results were analysed using Clinical and Laboratory Standards Institute breakpoints from January 2012. Of the key resistances, non-susceptibility to the third-generation cephalosporin, ceftriaxone, was found in 3.2% of E. coli and 3.2%-4.0% of Klebsiella spp. Non-susceptibility rates to ciprofloxacin were 5.4% for E. coli, 1.0%-2.3% for Klebsiella spp., and 2.5%-6.6% in Enterobacter spp, and resistance rates to piperacillin-tazobactam were 2.8%, 3.2%-6.9%, and 16.8%-18.0% for the same 3 groups respectively. Only 3 strains, 2 Klebsiella spp. and 1 Enterobacter spp, were shown to harbour a carbapenemase (IMP-4). | |
dc.title | Australian Group on Antimicrobial Resistance Community-onset Gram-negative Surveillance Program annual report, 2010 | |
dc.type | Journal Article | |
dcterms.source.volume | 37 | |
dcterms.source.number | 3 | |
dcterms.source.startPage | E219 | |
dcterms.source.endPage | E223 | |
dcterms.source.issn | 1447-4514 | |
dcterms.source.title | Communicable diseases intelligence quarterly report | |
curtin.department | School of Biomedical Sciences | |
curtin.accessStatus | Fulltext not available |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |